Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial
Multiples Valuation: Elevance Health Inc.

Elevance Health Inc. (ELV)

Industry: Medical - Healthcare Plans Model: Peers Multiples Valuation

Valuation Snapshot

Winsorized Fair Value
Range (Low - High) $303.55 — $413.08
Selected (Average) $375.81
Upside to Live 0.25%
Full Range Fair Value
Range (Low - High) $372.31 — $596.08
Selected (Average) $462.37
Upside to Live 23.34%
Live Price $374.87

Industry Peers Data

TickerRankNameRev TTM (M) Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
UNH 1 UnitedHealth Group 435,159 17.83 17.65 12.01 11.70 21.23 13.64
CVS 2 CVS Health Corpora 394,084 203.99 359.31 15.87 17.69 - 42.45
CI 3 Cigna Corporation 268,129 12.48 12.12 8.46 8.28 10.16 11.24
ELV 4 Elevance Health In 194,820 13.19 12.90 6.51 6.32 9.27 8.57
HUM 5 Humana Inc. 126,362 24.28 30.67 12.06 13.91 71.95 28.77
MOH 6 Molina Healthcare, 54,066 11.62 11.41 6.50 6.30 18.04 7.36
OSCR 7 Oscar Health, Inc. 11,289 - - - - - -
GTS 8 Triple-S Managemen 4,115 10.24 7.70 4.76 3.71 12.00 7.18
ALHC 9 Alignment Healthca 3,637 - - 109.75 109.75 103.65 1,278.45
CLOV 10 Clover Health Inve 1,774 - - - - - -
BHG 11 Bright Health Grou 734 0.08 0.08 -0.08 -0.08 -1.00 -0.13
0314.HK 12 Sipai Health Techn 486 - - - - - -
ODPV3.SA 13 Odontoprev S.A. 434 12.56 11.37 6.34 5.50 10.15 10.97
QUAL3.SA 14 Qualicorp Consulto 267 73.07 152.74 2.64 2.82 7.11 9.03
000503.SZ 15 China Reform Healt 46 - - - - - -
7083.T 16 AHC Group Inc. 42 40.46 40.46 14.65 14.65 21.48 47.10

Implied Valuation Analysis

Line Item Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
Winsorized Median Multiple12.5612.128.468.2812.0011.24
Full Range Median Multiple15.1914.8810.239.9918.0412.44
Industry Multiple40.6664.3519.3119.4330.64145.62
Market Implied Multiple15.3014.967.677.4510.9410.10
Company (ELV) Multiple13.1912.906.516.329.278.57
(*) Net Income / EBITDA / Revenue5,5335,65610,01510,3207,0287,607
Winsorized Enterprise ValueN/AN/A84,73985,40984,32185,489
Full Range Median Enterprise ValueN/AN/A102,488103,092126,81094,635
(-) Net Debt-7,784-7,784-7,784-7,784-7,784-7,784
Winsorized Equity Value69,50768,54192,52393,19392,10593,273
Full Range Median Equity Value84,06784,184110,272110,876134,594102,419
(/) Shares Outstanding226226226226226226
Winsorized Fair Value$307.82$303.55$409.76$412.72$407.91$413.08
Full Range Median Fair Value$372.31$372.82$488.36$491.04$596.08$453.58
Current Price$374.87$374.87$374.87$374.87$374.87$374.87
Upside / Downside-17.89%-19.03%9.31%10.10%8.81%10.19%
Safety Margin30.0%30.0%30.0%30.0%30.0%30.0%
Buy Price$215.48$212.48$286.83$288.91$285.53$289.15
Buy / Don't BuyDon’t BuyDon’t BuyDon’t BuyDon’t BuyDon’t BuyDon’t Buy